MaxCyte Inks Platform License With Vertex For Gene-Editing Program For Rare Blood Disorders
MaxCyte Inc (NASDAQ: MXCT) has signed a
Rallybio’s Thrombocytopenia Candidate Shows Rapid, Complete Elimination Of Transfused Platelets
Rallybio Corporation (NASDAQ:RLYB) announced preliminary results from its ongoing Phase 1b proof-of-concept study of RLYB212 to prevent fetal and neonatal alloimmune…
KemPharm’s Lead Prodrug Shows Favorable Safety Profile For Rare Sleeping Disorder
KemPharm Inc (NASDAQ:KMPH) announced topline data from its exploratory Phase 1 trial confirming the relative cardiovascular effects and pharmacokinetics of serdexmethylphenidate…
OraSure Secures BARDA Funding For Next-Gen Ebola Diagnostic Test
The Biomedical Advanced Research and Development Authority (BARDA) has issued an $8.6 million contract to OraSure Technologies Inc (NASDAQ:OSUR) for developing a…
ASLAN Pharmaceuticals Presents New Data From Atopic Dermatitis Candidate
ASLAN Pharmaceuticals (NASDAQ:ASLN) announced the presentation of new translational eblasakimab data at the Annual European Society for Dermatological Research (ESDR) Meeting. …
Europe’s Health Agency Accepts Moderna’s Filing For Its Updated Omicron-Targeted COVID-19 Vaccine
The European Medicines Agency (EMA) has accepted a variation for evaluating Moderna Inc’s (NASDAQ:MRNA) 50 µg booster dose of the Omicron-containing…
Thermo Fisher’s Oncomine Dx Test Is First FDA Approved NGS-Based Companion Diagnostic To Detect Thyroid Cancers
The FDA approved Thermo Fisher Scientific Inc’s (NYSE:TMO) Oncomine Dx Target Test as a companion diagnostic (CDx) to select patients with RET-fusion…
FDA Approves First Branded Ocular Anesthetic In Almost 14 Years
The FDA approved Harrow Health Inc (NASDAQ:HROW) and Sintetica S.A’s Iheezo (chloroprocaine hydrochloride ophthalmic gel) 3% for ocular surface anesthesia. Iheezo is a…
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
The FDA said it will now review only a small number of emergency use authorization (EUA) requests for COVID-19 diagnostic…